Valneva to present on its single-shot chikungunya vaccine candidate at leading scientific conferences

Saint- herb lain (france ) , october 10 , 2 02 2 – valneva se (nasdaq: valn; euronext paris: vla), a specialty vaccine company, announces today it will present on its single-shot chikungunya vaccine candidate at several leading scientific conferences during the fourth quarter of 2022.
VALN Ratings Summary
VALN Quant Ranking